دورية أكاديمية
A case of severe psoriatic erythroderma with COVID-19.
| العنوان: | A case of severe psoriatic erythroderma with COVID-19. |
|---|---|
| المؤلفون: | Ghalamkarpour F; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Pourani MR; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Abdollahimajd F; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Clinical Research Development Unit, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Zargari O; Dana Clinic, Rasht, Iran. |
| المصدر: | The Journal of dermatological treatment [J Dermatolog Treat] 2022 Mar; Vol. 33 (2), pp. 1111-1113. Date of Electronic Publication: 2020 Aug 04. |
| نوع المنشور: | Case Reports; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-1753 (Electronic) Linking ISSN: 09546634 NLM ISO Abbreviation: J Dermatolog Treat Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: London : Informa Healthcare Original Publication: Houndmills, Basingstoke, Hampshire, UK : M. Dunitz and Macmillan Press, [c1989]- |
| مواضيع طبية MeSH: | COVID-19*/complications , Dermatitis, Exfoliative*/drug therapy , Dermatitis, Exfoliative*/etiology, Cyclosporine/therapeutic use ; Humans ; Male ; Middle Aged ; Pandemics ; SARS-CoV-2 |
| مستخلص: | COVID-19 caused by the SARS-CoV-2, became pandemic very quickly. Management of severe dermatologic disorders in patients who require systemic immunosuppressive treatment is a major concern in COVID-19 pandemic era. Here, we report a 45-year-old homeless addicted male with second flare of psoriatic erythroderma and positive PCR test for COVID 19. His first attack occurred two months earlier, when he was screened for SARS-CoV-2 before admission which all evaluations showed nagative results. The patient was treated and relatively controlled with cyclosporine and therefore he was discharged. During this interval, he not only discontinued his medication, but also became SARS-CoV-2 positive. It seems that both factors participated in flare of his erythroderma. |
| فهرسة مساهمة: | Keywords: COVID-19; SARS-CoV-2; erythroderma; psoriasis |
| المشرفين على المادة: | 83HN0GTJ6D (Cyclosporine) |
| تواريخ الأحداث: | Date Created: 20200722 Date Completed: 20220407 Latest Revision: 20220407 |
| رمز التحديث: | 20221213 |
| DOI: | 10.1080/09546634.2020.1799918 |
| PMID: | 32691645 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 1471-1753 |
|---|---|
| DOI: | 10.1080/09546634.2020.1799918 |